The peptides under consideration this week are: BPC-157, proposed for treating ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTs-C for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The FDA advisory committee will be determining whether or not it will allow access to these substances through legitimate state-licensed compounding pharmacies, said Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, who sent a public letter to the committee in support of adding peptides to the list
For a single discrete tendon injury with an identifiable injection site, BPC-157 is typically more effective because it activates the fibroblasts that produce collagen directly at the repair location
The peptide has demonstrated protection against further joint damage in animal models
Formulated specifically for peptide research, this Bacteriostatic Water prevents bacterial growth, reducing the risk of contamination that could interfere with research
Triple Lab Tested: Rigorously tested by independent third-party labs to verify potency and purity
Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s